BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $828,000 | -4.4% | 10,295 | +2.4% | 0.03% | -53.2% |
| Q2 2020 | $866,000 | +5.4% | 10,054 | -0.7% | 0.06% | -13.9% |
| Q1 2020 | $822,000 | -0.5% | 10,129 | +2.6% | 0.07% | +30.9% |
| Q4 2019 | $826,000 | -3.7% | 9,873 | +0.7% | 0.06% | -12.7% |
| Q3 2019 | $858,000 | +7.0% | 9,805 | +0.2% | 0.06% | +5.0% |
| Q2 2019 | $802,000 | +48.8% | 9,790 | +47.7% | 0.06% | +46.3% |
| Q1 2019 | $539,000 | +19.0% | 6,628 | -3.8% | 0.04% | +2.5% |
| Q4 2018 | $453,000 | -16.4% | 6,887 | -2.0% | 0.04% | -11.1% |
| Q3 2018 | $542,000 | +3.2% | 7,027 | -1.2% | 0.04% | -6.2% |
| Q2 2018 | $525,000 | -0.9% | 7,112 | -12.8% | 0.05% | -4.0% |
| Q1 2018 | $530,000 | -4.8% | 8,153 | -5.4% | 0.05% | -7.4% |
| Q4 2017 | $557,000 | +6.9% | 8,620 | +3.8% | 0.05% | -5.3% |
| Q3 2017 | $521,000 | -1.1% | 8,307 | -4.6% | 0.06% | -8.1% |
| Q2 2017 | $527,000 | +266.0% | 8,704 | +213.5% | 0.06% | +210.0% |
| Q1 2017 | $144,000 | +21.0% | 2,776 | +3.9% | 0.02% | +11.1% |
| Q4 2016 | $119,000 | -22.2% | 2,673 | -16.7% | 0.02% | -25.0% |
| Q3 2016 | $153,000 | +0.7% | 3,207 | -4.6% | 0.02% | -4.0% |
| Q2 2016 | $152,000 | -38.0% | 3,360 | -43.6% | 0.02% | -41.9% |
| Q1 2016 | $245,000 | -38.8% | 5,962 | -43.2% | 0.04% | -41.9% |
| Q4 2015 | $400,000 | – | 10,488 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |